Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017—Utility and Limitations

Pan-Assay Interference Compounds (PAINS) are very familiar to medicinal chemists who have spent time fruitlessly trying to optimize these nonprogressible compounds. Electronic filters formulated to recognize PAINS can process hundreds and thousands of compounds in seconds and are in widespread current use to identify PAINS in order to exclude them from further analysis. However, this practice is fraught with danger because such black box treatment is simplistic. Here, we outline for the first time all necessary considerations for the appropriate use of PAINS filters.

[1]  Ian A. Watson,et al.  Rules for identifying potentially reactive or promiscuous compounds. , 2012, Journal of medicinal chemistry.

[2]  Petra Schneider,et al.  Privileged Structures Revisited , 2017, Angewandte Chemie.

[3]  Karl-Johan Leuchowius,et al.  A perspective on 10-years HTS experience at the Walter and Eliza Hall Institute of Medical Research - eighteen million assays and counting. , 2014, Combinatorial chemistry & high throughput screening.

[4]  Jayme L. Dahlin,et al.  Assay Interference by Chemical Reactivity , 2015 .

[5]  J Willem M Nissink,et al.  Quantification of frequent-hitter behavior based on historical high-throughput screening data. , 2014, Future medicinal chemistry.

[6]  P. Kenny,et al.  Comment on The Ecstasy and Agony of Assay Interference Compounds , 2017, J. Chem. Inf. Model..

[7]  Jonathan B. Baell,et al.  Redox-active nuisance screening compounds and their classification , 2011 .

[8]  James Inglese,et al.  Assay Interference by Chemical Reactivity -- Assay Guidance Manual , 2004 .

[9]  J. Baell,et al.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.

[10]  J. Baell,et al.  Chemistry: Chemical con artists foil drug discovery , 2014, Nature.

[11]  George Nikolakopoulos,et al.  An Efficient High-Throughput Screening Method for MYST Family Acetyltransferases, a New Class of Epigenetic Drug Targets , 2011, Journal of biomolecular screening.

[12]  Yanli Wang,et al.  PubChem BioAssay: 2017 update , 2016, Nucleic Acids Res..

[13]  Tudor I. Oprea,et al.  Badapple: promiscuity patterns from noisy evidence , 2016, Journal of Cheminformatics.

[14]  Jayme L. Dahlin,et al.  PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS , 2015, Journal of medicinal chemistry.

[15]  Jianghong An,et al.  Salicylates are interference compounds in TR-FRET assays. , 2016, Bioorganic & medicinal chemistry letters.

[16]  Alexander Tropsha,et al.  Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS , 2017, J. Chem. Inf. Model..

[17]  Wolfgang Guba,et al.  Development of a virtual screening method for identification of "frequent hitters" in compound libraries. , 2002, Journal of medicinal chemistry.

[18]  Bohdan Waszkowycz,et al.  First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to Olaparib. , 2016, ACS chemical biology.

[19]  Kristin E. D. Coan,et al.  Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors. , 2008, Journal of the American Chemical Society.

[20]  Jürgen Bajorath,et al.  How Frequently Are Pan-Assay Interference Compounds Active? Large-Scale Analysis of Screening Data Reveals Diverse Activity Profiles, Low Global Hit Frequency, and Many Consistently Inactive Compounds. , 2017, Journal of medicinal chemistry.

[21]  Stephen Gabriel,et al.  Metal impurities cause false positives in high-throughput screening campaigns. , 2013, ACS medicinal chemistry letters.

[22]  Renaldo Mendoza,et al.  ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens. , 2005, Journal of the American Chemical Society.

[23]  Olivier Sperandio,et al.  FAF-Drugs3: a web server for compound property calculation and chemical library design , 2015, Nucleic Acids Res..

[24]  John P. Overington,et al.  The promise and peril of chemical probes. , 2015, Nature chemical biology.

[25]  Andrew C. Good,et al.  An Empirical Process for the Design of High-Throughput Screening Deck Filters , 2006, J. Chem. Inf. Model..

[26]  Jonathan B Baell,et al.  Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS). , 2016, Journal of natural products.

[27]  George Nikolakopoulos,et al.  PAINS: Relevance to Tool Compound Discovery and Fragment-Based Screening , 2013 .

[28]  Kenneth M Merz,et al.  The Ecstasy and Agony of Assay Interference Compounds. , 2017, ACS chemical neuroscience.

[29]  Jonathan B. Baell,et al.  Broad Coverage of Commercially Available Lead-like Screening Space with Fewer than 350, 000 Compounds , 2013, J. Chem. Inf. Model..

[30]  J. Baell.  Observations on screening-based research and some concerning trends in the literature. , 2010, Future medicinal chemistry.

[31]  J Willem M Nissink,et al.  Promiscuous 2-aminothiazoles (PrATs): a frequent hitting scaffold. , 2015, Journal of medicinal chemistry.

[32]  Jonathan B Baell,et al.  Screening-based translation of public research encounters painful problems. , 2015, ACS medicinal chemistry letters.

[33]  Rajarshi Guha,et al.  KNIME Workflow to Assess PAINS Filters in SMARTS Format. Comparison of RDKit and Indigo Cheminformatics Libraries , 2011, Molecular informatics.